Sandoz Inc. is recalling 1,680 bottles of Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, an ear-drop medication used to treat ear infections. The recall was initiated due to "temperature abuse," meaning the product was exposed to temperatures outside of its required storage range during distribution. This exposure can compromise the stability and effectiveness of the medication. The affected products were distributed to a single consignee in California.
Exposure to improper temperatures can degrade the active ingredients or physical stability of the ear drops, potentially making the medication less effective at treating the underlying ear infection.
You have 2 options:
Manufactured By: Novartis Manufacturing NV, Belgium; Distributed by: Sandoz, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.